comprehensive -WSS

comprehensive

author：fashion 2025-10-01 03:47:01 Page View：42442

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sanofi strikes deal with Novavax, boosting the vaccine maker
Next article： Wildfire smoke exposes gaps in outdoor worker protections

Wikipedia

Hollywood unions extend contract negotiations for actors

1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

What nurses really want: sufficient staffing for patient care

AdobePizza.Coloringbooks.Goodybags.Theycouldbeactivitiesata5-year-old’sbirthdayparty.Butthey’renot:T

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Eli Lilly expects to double planned employment in Boston center

Anartist'srenderingofthebuilding—currentlyunderconstructionalongBoston'sFortPointChannel—whereEliLil

comprehensive

focus

Wikipedia

Eli Lilly expects to double planned employment in Boston center